Astrazeneca (AZN) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for Astrazeneca (AZN) over the last 16 years, with Q4 2025 value amounting to $135.0 million.
- Astrazeneca's Interest & Investment Income rose 11093.75% to $135.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $372.0 million, marking a year-over-year decrease of 1877.73%. This contributed to the annual value of $360.0 million for FY2025, which is 2139.74% down from last year.
- Astrazeneca's Interest & Investment Income amounted to $135.0 million in Q4 2025, which was up 11093.75% from $85.0 million recorded in Q3 2025.
- In the past 5 years, Astrazeneca's Interest & Investment Income ranged from a high of $183.0 million in Q3 2024 and a low of $1.0 million during Q4 2021
- In the last 5 years, Astrazeneca's Interest & Investment Income had a median value of $66.0 million in 2023 and averaged $65.4 million.
- In the last 5 years, Astrazeneca's Interest & Investment Income crashed by 8137.59% in 2021 and then soared by 440000.0% in 2022.
- Over the past 5 years, Astrazeneca's Interest & Investment Income (Quarter) stood at $1.0 million in 2021, then soared by 4400.0% to $45.0 million in 2022, then surged by 140.0% to $108.0 million in 2023, then plummeted by 40.74% to $64.0 million in 2024, then soared by 110.94% to $135.0 million in 2025.
- Its last three reported values are $135.0 million in Q4 2025, $85.0 million for Q3 2025, and $68.0 million during Q2 2025.